- Home
- EHTH vs RPTX Comparison
EHTH vs RPTX Comparison
Compare EHTH & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- RPTX
- Stock Information
- Founded
- EHTH 1997
- RPTX 2016
- Country
- EHTH United States
- RPTX Canada
- Employees
- EHTH N/A
- RPTX N/A
- Industry
- EHTH Specialty Insurers
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- RPTX Health Care
- Exchange
- EHTH Nasdaq
- RPTX Nasdaq
- Market Cap
- EHTH 247.3M
- RPTX 141.1M
- IPO Year
- EHTH 2006
- RPTX 2020
- Fundamental
- Price
- EHTH $8.32
- RPTX $1.32
- Analyst Decision
- EHTH Hold
- RPTX Strong Buy
- Analyst Count
- EHTH 5
- RPTX 3
- Target Price
- EHTH $7.70
- RPTX $7.00
- AVG Volume (30 Days)
- EHTH 344.0K
- RPTX 709.5K
- Earning Date
- EHTH 11-06-2024
- RPTX 11-07-2024
- Dividend Yield
- EHTH N/A
- RPTX N/A
- EPS Growth
- EHTH N/A
- RPTX N/A
- EPS
- EHTH N/A
- RPTX N/A
- Revenue
- EHTH $464,891,000.00
- RPTX $66,524,000.00
- Revenue This Year
- EHTH $9.78
- RPTX $13.22
- Revenue Next Year
- EHTH $5.99
- RPTX N/A
- P/E Ratio
- EHTH N/A
- RPTX N/A
- Revenue Growth
- EHTH 15.78
- RPTX 18.19
- 52 Week Low
- EHTH $3.58
- RPTX $1.23
- 52 Week High
- EHTH $9.45
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- EHTH 81.77
- RPTX 30.27
- Support Level
- EHTH $5.42
- RPTX $1.23
- Resistance Level
- EHTH $8.98
- RPTX $4.07
- Average True Range (ATR)
- EHTH 0.48
- RPTX 0.34
- MACD
- EHTH 0.30
- RPTX -0.20
- Stochastic Oscillator
- EHTH 82.16
- RPTX 3.34
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.